Inhibitory activity of cephalexin, cephradine, and cefaclor was compared by the WHO-ICS agar dilution technique. Cefaclor was substantially more active against staphylococci, streptococci, gonococci, meningococci, Haemophilus, Escherichia coli, Klebsiella pneumoniae, Citrobacter diversus, Proteus mirabilis, salmonellae, and shigellae than was cephalexin, which in turn was more active than cephradine. Cefaclor appeared to be less resistant to staphylococcal penicillinase than did the other two agents. None of these cephalosporins was active against Enterobacter, Serratia, indole-positive Proteeae, Pseudomonas, or Bacteroides fragilis.
Antibiotics. Standard laboratory powders of cephalexin monohydrate and cefaclor (compound 99638) were kindly provided by Eli Lilly Laboratories for Clinical Research, Indianapolis, Ind. Cephradine was kindly provided by Smith, Kline, and French Co., Philadelphia, Pa. Susceptibility studies. MICs were determined by the agar dilution method (13) . Generally, MuellerHinton agar (MHA) containing each antibiotic diluted according to the WHO-ICS scheme (2) was inoculated with, unless indicated otherwise, a standardized inoculum of 104 colony-forming units (CFU) by using the replicator device of Steers et al. (9) . For testing streptococci other than group D, 5% defibrinated sheep blood was added to the MHA.
The plates were examined after 18 h ofincubation at 35°C. The MIC was interpreted as the lowest concentration of antibiotic yielding no growth, a barely visible haze, or no more than one discrete colony.
MHA supplemented with 1% IsoVitaleX (BBL) and 2% hemoglobin solution (Difco) was used to test Neisseria and Haemophilus (14) . The inocula were prepared by scraping growth from chocolate blood agar plates into Mueller-Hinton broth. The turbidity of each suspension was adjusted to match that of a one-half McFarland no. 1 standard. A 1:10 dilution of the adjusted suspension was then delivered onto the surfaces of the agar plates with an inocula replicator apparatus (9) . To test the effect of increasing the inoculum size of Haemophilus, the turbidity of the suspension was adjusted to match a no. 4 McFarland standard, and the suspension was directly inoculated onto the agar plates with the replicator device. After inoculation, the plates were incubated at 35°C in 5% CO2 for 18 h. The MICs were interpreted by the same criteria as above.
The MICs of anaerobic bacteria were determined according to the agar dilution procedure described in the Wadsworth Anaerobic Bacteriology Manual (10) . In this method, three to four colonies ofthe anaerobe were inoculated into supplemented thioglycolate medium without indicator (BBL-135C) which was enriched with hemin (5 ,ug/ml) before sterilization, plus NaHCO3 (1 mg/ml) and vitamin K, (0.1 ,ug/ml) added just before use. After anaerobic overnight incubation in a GasPak jar (BBL) at 35°C, the culture was diluted with brucella broth containing 5% Fildes enrichment (Difco) and vitamin K, (0.1 ,ugl ml) so that its turbidity matched that of one-half the turbidity of the no. 1 McFarland standard. Using the inocula replicator device, the adjusted broth culture was applied to plates of brucella agar base containing serial twofold dilutions of antibiotic at fimal concentrations ranging from 0.125 to 128 ,ug/ml and supplemented with vitamin K, (10 jug/ml) and 5% laked blood. The plates were incubated at 35°C in GasPak jars (BBL) for approximately 48 h. The MICs of each strain were read as the lowest concentration of drug yielding no growth, a barely visible haze, or no more than one discrete colony.
Minimum bactericidal concentrations (MBCs) were performed according to the method described by Washington (12) . Inoculum was prepared by subculturing portions of four or five isolated colonies of the organism into 5 ml of Mueller-Hinton broth and incubating the suspension for approximately 6 h. After the turbidity of the suspension was adjusted to match that of a no. 1 McFarland standard, it was diluted 1:10 to yield an inoculum of about 107 CFU/ ml and 1:1,000 to yield an inoculum of about 105 CFU/ml. Each of the tubes was inoculated with 0.5 ml of the adjusted broth culture. MICs were read after 18 h of incubation at 350C as the lowest concentration of antibiotic completely inhibiting visible growth. For the bactericidal phase, 0.5-ml aliquots from those tubes exhibiting no visible growth were used to prepare pour plates with brain heart infusion agar, which were read after 72 h of incubation at 350C.
RESULTS
The susceptibilities of gram-positive cocci and gram-negative bacilli to the three cephalosporins are shown in Table 1 . Cefaclor was generally more active than cephalexin or cephradine against both penicillin-susceptible and penicillin-resistant strains of S. aureus and S. epidermidis. At 2 ,ug/ml, cephalexin, cephradine, and cefaclor inhibited 17, 9, and 32%, respectively, ofpenicillin-resistant strains of S. aureus and 50, 25, and 80%, respectively, of penicillin-susceptible strains. At 4 ,tg/ml, 95% of penicillin-susceptible strains of S. aureus were inhibited by cefaclor, in contrast to 80% of strains inhibited by the other two antibiotics. At least 93% of penicillin-resistant strains of S. aureus were inhibited by cephalexin and cefaclor at 8 ,ug/ml, in contrast to 84% inhibited by cephradine at this level. The effects of inoculum size ofS. aureus on the activities of the three cephalosporins are noted in Fig. 1 . A factor for each antibiotic was calculated by dividing the MIC obtained with an inoculum of 107 CFU/ml by that obtained with an inoculum of 105 CFU/ml, as described elsewhere by Sabath et al. (7) . The factors for cephalexin, cephradine, and cefaclor were c8, -16, and c64, respectively. Cefaclor was highly effective against group A and group B streptococci and inhibited all strains tested at 0.25 and 2.0 ug/ml, respectively. All strains of Streptococcus pneumoniae were inhibited by 1.0 ,ug/ ml. All of the 21 strains of pathogenic Neisseria were inhibited by 0.25 ,ug of cefaclor per ml, whereas 4 ,ug of cephalexin and 4 to 8 ,ug of cephradine per ml were required to achieve the same results. The lowest concentrations ofthe three cephalosporins inhibiting at least 90% of facultatively anaerobic gram-negative bacilli are also shown in Table 1 . At 4 ,ug/ml, cefaclor was more effective than cephalexin or cephradine against E. coli, with 83, 35, and 5%, respectively, of the 195 strains inhibited at this concentration. Cephalexin and cefaclor were more effective than cephradine against E. coli at 8 ,ug/ml, with 84, 93, and 55%, respectively, of the strains being inhibited. Similar results were obtained for Klebsiella pneumoniae. The three cephalosporins had little or no effect on Enterobacter aerogenes, E. cloacae, Serratia marcescens, indole-positive Proteus, Citrobacter freundii, Providencia stuartii, and Pseudomonas. Citrobacter diversus, Salmonella, and Shigella were highly susceptible to cefa- clor, with 83, 95, and 75%, respectively, being inhibited with 2 jig/ml. To obtain similar results, a four-to eightfold increase in the concentrations of cephalexin and cephradine was required for this purpose. Proteus mirabilis was more susceptible to cefaclor than cephalexin and cephradine, although 32 ,ug of cefaclor per ml was required to inhibit 75% of the 32 strains tested.
The effects of inoculum size and the effect of the presence of,-lactamase on the susceptibility of H. influenzae to cephalexin, cephradine, and cefaclor are shown in Table 2 . A significant inoculum effect was demonstrated for all three antibiotics with both /3-lactamase-positive and 3-lactamase-negative H. influenzae. The presence of (8-lactamase did not affect the activity of cefaclor but did affect the activity of cephalexin and cephradine. Inhibition ofH. influenzae was achieved with only 2 ,ug of cefaclor per ml, in contrast to 8 Ag of cephalexin and 16 ,ug of cephradine per ml needed for ,B-lactamase-negative organisms, and 32 ,ug ofcephalexin and 64 ,ug of cephradine per ml needed for /8-lactamase-positive organisms.
The activities of the three antibiotics against Bacteroides fragilis, B. melaninogenicus, and anaerobic gram-positive cocci are listed in Table 3 . Cephalexin, cephradine, and especially cefaclor had little effect onB. fragilis. At 64 ,ug/ ml, both cephalexin and cephradine inhibited 83% of the 18 strains of B. fragilis, whereas cefaclor inhibited only 11%. B. melaninogenicus was more susceptible to the cephalosporins than was B. fragilis, particularly if the strains of B. melaninogenicus were inhibited by penicillin at concentrations of '0.5 pAg/ml. Cephalexin, cephradine, and cefaclor required 1, 2, and 0.5 ,g/ml, respectively, for inhibition ofB. Neither cefaclor nor cephradine produced 100% killing of 105 and 107 CFU of penicillinsusceptible and penicillin-resistant strains ofS. aureus per ml at concentrations of s 128 ug/ml. With one exception, neither cefaclor nor cephradine produced 99.9% killing of staphylococci in an inoculum of 107 CFU/ml. With one strain, cephradine produced 99.9% killing at 32 ,ug/ml. The MBC values of cefaclor against three strains of E. coli were the same as, two times (in the first two instances) and eight times the MIC values, respectively. With three strains ofK. pneumoniae, the MBC values were four times the MIC values in two instances and twice the MIC value in one instance. DISCUSSION Against both penicillinase-and non-penicillinase-producing strains of S. aureus, cefaclor was at least three times as active as cephradine at 2 ug/ml and at least one and a half times as active as cephalexin at this concentration. The effects of inoculum size of S. aureus on the activities of the three cephalosporins varied substantially (Fig. 1) , with cephalexin being the least affected by penicillinase-producing strains and cefaclor being the most affected by such strains; cephradine was intermediate between the two. Similar studies by Sabath et al. (7) have shown that cephalexin was only slightly less resistant to staphylococcal penicillinase than was cephalothin. These data disagree with those reported by Fong et al. (3) , who assayed for residual cephalosporin activity in broth cultures ofS. aureus and found that cephalexin was completely inactivated by staphylococcal penicillinase within 12 h, in contrast to cephalothin, which underwent little inactivation. They also found that cephradine, which was not tested by Sabath et al. (7) , was degraded more slowly than cephalexin, with 18% of the original concentration being measurable at 12 h. Cephradine was found to be more resistant than cephalexin to crude ,8-lactamase derived from S. aureus by Hubsher et al. (4) .
At 2 ug/ml, cefaclor inhibited all /8-lactamase-positive and -negative strains ofH. influenzae at the generally recommended inoculum of 104 CFU/ml (11) , in contrast to cephalexin and cephradine, which required substantially greater concentrations to achieve the same order ofactivity and which were also considerably affected by Haemophilus /8-lactamase. None of the cephalosporins inhibited a significant number of the strains ofH. influenzae at the higher inoculum size. Our results with cephalexin and cephradine are similar to those reported by Emerson et cephradine, and cefaclor per ml, respectively, for complete inhibition.
In conclusion, we have found cefaclor to be substantially more active than cephalexin, which in turn was more active than cephradine, against staphylococci, streptococci, gonococci, meningococci, and certain species of the Enterobacteriaceae. Cefaclor was also highly active against both ,B-lactamase-positive and -negative strains ofH. influenzae at the recommended inoculum size. Clinical studies are required to substantiate cefaclor's value in the therapy of infections due to these susceptible species.
